<HashMap><database>biostudies-literature</database><scores/><additional><submitter>van der Made CI</submitter><funding>European Research Council</funding><funding>Wellcome Trust</funding><pagination>791-804</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11023912</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>111(4)</volume><pubmed_abstract>Mutations in proteasome β-subunits or their chaperone and regulatory proteins are associated with proteasome-associated autoinflammatory disorders (PRAAS). We studied six unrelated infants with three de novo heterozygous missense variants in PSMB10, encoding the proteasome β2i-subunit. Individuals presented with T-B-NK± severe combined immunodeficiency (SCID) and clinical features suggestive of Omenn syndrome, including diarrhea, alopecia, and desquamating erythematous rash. Remaining T cells had limited T cell receptor repertoires, a skewed memory phenotype, and an elevated CD4/CD8 ratio. Bone marrow examination indicated severely impaired B cell maturation with limited V(D)J recombination. All infants received an allogeneic stem cell transplant and exhibited a variety of severe inflammat</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome.</pubmed_title><pmcid>PMC11023912</pmcid><funding_grant_id>310372</funding_grant_id><pubmed_authors>Lev A</pubmed_authors><pubmed_authors>Simons A</pubmed_authors><pubmed_authors>Griffin H</pubmed_authors><pubmed_authors>Gennery AR</pubmed_authors><pubmed_authors>Loo PS</pubmed_authors><pubmed_authors>Esteki MZ</pubmed_authors><pubmed_authors>Segev M</pubmed_authors><pubmed_authors>van de Veerdonk FL</pubmed_authors><pubmed_authors>Schuurs-Hoeijmakers JHM</pubmed_authors><pubmed_authors>Kersten S</pubmed_authors><pubmed_authors>Essers R</pubmed_authors><pubmed_authors>Pfundt R</pubmed_authors><pubmed_authors>Simon AJ</pubmed_authors><pubmed_authors>Schim van der Loeff I</pubmed_authors><pubmed_authors>Avital AL</pubmed_authors><pubmed_authors>Engelhardt KR</pubmed_authors><pubmed_authors>Slatter MA</pubmed_authors><pubmed_authors>Mantere T</pubmed_authors><pubmed_authors>Frizinsky S</pubmed_authors><pubmed_authors>Flood T</pubmed_authors><pubmed_authors>Venselaar H</pubmed_authors><pubmed_authors>Netea MG</pubmed_authors><pubmed_authors>Barel O</pubmed_authors><pubmed_authors>Henriet SSV</pubmed_authors><pubmed_authors>Chorin O</pubmed_authors><pubmed_authors>Rothschild AR</pubmed_authors><pubmed_authors>Ramakrishnan G</pubmed_authors><pubmed_authors>Seyger MM</pubmed_authors><pubmed_authors>van der Burg M</pubmed_authors><pubmed_authors>Hambleton S</pubmed_authors><pubmed_authors>van der Made CI</pubmed_authors><pubmed_authors>Hoischen A</pubmed_authors><pubmed_authors>Warris A</pubmed_authors><pubmed_authors>Somech R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome.</name><description>Mutations in proteasome β-subunits or their chaperone and regulatory proteins are associated with proteasome-associated autoinflammatory disorders (PRAAS). We studied six unrelated infants with three de novo heterozygous missense variants in PSMB10, encoding the proteasome β2i-subunit. Individuals presented with T-B-NK± severe combined immunodeficiency (SCID) and clinical features suggestive of Omenn syndrome, including diarrhea, alopecia, and desquamating erythematous rash. Remaining T cells had limited T cell receptor repertoires, a skewed memory phenotype, and an elevated CD4/CD8 ratio. Bone marrow examination indicated severely impaired B cell maturation with limited V(D)J recombination. All infants received an allogeneic stem cell transplant and exhibited a variety of severe inflammat</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-01T22:16:06.205Z</modification><creation>2025-04-04T00:34:19.961Z</creation></dates><accession>S-EPMC11023912</accession><cross_references><pubmed>38503300</pubmed><doi>10.1016/j.ajhg.2024.02.013</doi></cross_references></HashMap>